HuGE Literature Finder
Records
1
-
7
Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17-beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways through distinct mechanisms. Hepatology communications 2022 4 6 (8): 1934-1948. Hudert Christian A, Adams Leon A, Alisi Anna, Anstee Quentin M, Crudele Annalisa, Draijer Laura G, Furse Samuel, Hengstler Jan G, Jenkins Benjamin, Karnebeek Kylie, Kelly Deirdre A, Koot Bart G, Koulman Albert, Meierhofer David, Melton Phillip E, Mori Trevor A, Snowden Stuart G, van Mourik Indra, Vreugdenhil Anita, Wiegand Susanna, Mann Jake P, |
Metabolic and Genetic Risk Factors Are the Strongest Predictors of Severity of Alcohol-Related Liver Fibrosis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2020 Dec . Israelsen Mads, Juel Helene Bæk, Detlefsen Sönke, Madsen Bjørn Stæhr, Rasmussen Ditlev Nytoft, Larsen Trine R, Kjærgaard Maria, Fernandes Jensen Mary Jo, Stender Stefan, Hansen Torben, Krag Aleksander, Thiele Maja, |
Attenuated effect of PNPLA3 on hepatic fibrosis by HSD17B13 in Japanese patients with non-alcoholic fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver 2020 Apr . Seko Yuya, Yamaguchi Kanji, Tochiki Nozomi, Yano Kota, Takahashi Aya, Okishio Shinya, Kataoka Seita, Okuda Keiichiroh, Umemura Atsushi, Moriguchi Michihisa, Tanaka Saiyu, Mori Kojiroh, Okanoue Takeshi, Itoh Yoshi |
HSD17B13 rs72613567 protects against liver diseases and histological progression of nonalcoholic fatty liver disease: a systematic review and meta-analysis. European review for medical and pharmacological sciences 2020 9 24 (17): 8997-9007. Wang P, Wu C-X, Li Y, Shen |
17-Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver Disease. Hepatology (Baltimore, Md.) 2019 Apr 69 (4): 1504-1519. Ma Yanling, Belyaeva Olga V, Brown Philip M, Fujita Koji, Valles Katherine, Karki Suman, de Boer Ynto S, Koh Christopher, Chen Yanhua, Du Xiaomeng, Handelman Samuel K, Chen Vincent, Speliotes Elizabeth K, Nestlerode Cara, Thomas Emmanuel, Kleiner David E, Zmuda Joseph M, Sanyal Arun J, , Kedishvili Natalia Y, Liang T Jake, Rotman Yar |
Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers.
![]() Alcoholism, clinical and experimental research 2019 Mar 43 (3): 473-482. Whitfield John B, Zhu Gu, Madden Pamela A F, Montgomery Grant W, Heath Andrew C, Martin Nicholas |
Splice variant rs72613567 prevents worst histologic outcomes in patients with nonalcoholic fatty liver disease. Journal of lipid research 2019 Jan 60 (1): 176-185. Pirola Carlos J, Garaycoechea Martin, Flichman Diego, Arrese Marco, San Martino Julio, Gazzi Carla, Castaño Gustavo O, Sookoian Silv |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 21, 2023
- Content source: